psalexa
logo

Transdermal Drug Delivery Systems Market

Transdermal Drug Delivery Systems Market by Type of Delivery System (Passive [Matrix System, Reservoir System], Active [Structure Based, Electrical Based {Iontophoresis, Electroporation, Sonophoresis}]), by Application (Analgesics, Hormone Replacement Therapy, Hypertension, Cardiovascular Disorders, Motion Sickness, Smoking Cessation), by Geography (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Saudi Arabia, South Africa) – Global Market Size, Share, Development, Growth and Demand Forecast, 2016-2023

Published: June 2017
Report Code: LS11380
Available Format:
Pages: 108

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Type

1.3.2 Market Segmentation by Application

1.3.3 Market Segmentation by Geography

1.3.4 Analysis Period

1.3.5 Market Data Reporting Unit

1.3.5.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Type

4.1.1.1 Passive

4.1.1.1.1 Matrix systems

4.1.1.1.2 Reservoir systems

4.1.1.2 Active

4.1.1.2.1 Electrical based

4.1.1.2.1.1 Iontophoresis

4.1.1.2.1.2 Electroporation

4.1.1.2.1.3 Sonophoresis

4.1.1.2.2 Structure based

4.1.1.2.3 Others

4.1.2 By Application

4.1.2.1 Analgesics

4.1.2.2 Hormone replacement therapy

4.1.2.3 Smoking cessation

4.1.2.4 Hypertension

4.1.2.5 Motion sickness

4.1.2.6 Others

4.2 Market Dynamics

4.2.1 Drivers

4.2.1.1 Increasing adoption of advanced transdermal delivery systems

4.2.1.2 Rising prevalence of chronic disorders

4.2.1.3 Growing geriatric population

4.2.1.4 Impact analysis of drivers on market forecast

4.2.2 Restraints

4.2.2.1 Drawbacks associated with transdermal delivery systems

4.2.2.2 Impact analysis of restraints on market forecast

4.2.3 Opportunities

4.2.3.1 Lucrative opportunities in emerging economies

Chapter 5. Global Market Size and Forecast

5.1 By Type

5.1.1 Passive Systems by Type

5.1.2 Active Systems by Type

5.1.2.1 Electrical based active systems by modality

5.2 By Application

5.3 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Type

6.1.1 Passive Systems by Type

6.1.2 Active Systems by Type

6.1.2.1 Electrical based active systems by modality

6.2 By Application

6.3 By Country

Chapter 7. Europe Market Size and Forecast

7.1 By Type

7.1.1 Passive Systems by Type

7.1.2 Active Systems by Type

7.1.2.1 Electrical based active systems by modality

7.2 By Application

7.3 By Country

Chapter 8. APAC Market Size and Forecast

8.1 By Type

8.1.1 Passive Systems by Type

8.1.2 Active Systems by Type

8.1.2.1 Electrical based active systems by modality

8.2 By Application

8.3 By Country

Chapter 9. LAMEA Market Size and Forecast

9.1 By Type

9.1.1 Passive Systems by Type

9.1.2 Active Systems by Type

9.1.2.1 Electrical based active systems by modality

9.2 By Application

9.3 By Country

Chapter 10. Competitive Landscape

10.1 Market Share Analysis of Key Players

Chapter 11. Company Profiles

11.1 Novartis AG

11.1.1 Business Overview

11.1.2 Product and Service Offerings

11.2 Johnson & Johnson

11.2.1 Business Overview

11.2.2 Product and Service Offerings

11.3 Mylan N.V.

11.3.1 Business Overview

11.3.2 Product and Service Offerings

11.4 Boehringer Ingelheim GmbH

11.4.1 Business Overview

11.4.2 Product and Service Offerings

11.5 Bayer AG

11.5.1 Business Overview

11.5.2 Product and Service Offerings

11.6 Purdue Pharma L.P.

11.6.1 Business Overview

11.6.2 Product and Service Offerings

11.7 GlaxoSmith Kline plc

11.7.1 Business Overview

11.7.2 Product and Service Offerings

11.8 3M Company

11.8.1 Business Overview

11.8.2 Product and Service Offerings

11.9 Echo Therapeutics Inc.

11.9.1 Business Overview

11.9.2 Product and Service Offerings

11.1 Endo International plc

11.10.1 Business Overview

11.10.2 Product and Service Offerings

Chapter 12. Appendix

12.1 Abbreviations

12.2 Sources and References

12.3 Related Reports

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 5 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 6 GLOBAL ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 7 GLOBAL ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)

TABLE 8 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)

TABLE 9 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY REGION, $M (2016–2023)

TABLE 10 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 11 NORTH AMERICA PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 12 NORTH AMERICA ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 13 NORTH AMERICA ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)

TABLE 14 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)

TABLE 15 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)

TABLE 16 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 17 EUROPE PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 18 EUROPE ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 19 EUROPE ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)

TABLE 20 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)

TABLE 21 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)

TABLE 22 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 23 APAC PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 24 APAC ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 25 APAC ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)

TABLE 26 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)

TABLE 27 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)

TABLE 28 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 29 LAMEA PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 30 LAMEA ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

TABLE 31 LAMEA ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)

TABLE 32 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)

TABLE 33 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)

TABLE 34 NOVARTIS AG – AT A GLANCE

TABLE 35 JOHNSON & JOHNSON - AT A GLANCE

TABLE 36 MYLAN N.V. – AT A GLANCE

TABLE 37 BOEHRINGER INGELHEIM GMBH – AT A GLANCE

TABLE 38 BAYER AG – AT A GLANCE

TABLE 39 PURDUE PHARMA L.P. – AT A GLANCE

TABLE 40 GLAXOSMITH KLINE PLC – AT A GLANCE

TABLE 41 3M COMPANY – AT A GLANCE

TABLE 42 ECHO THERAPEUTICS INC. – AT A GLANCE

TABLE 43 ENDO INTERNATIONAL PLC – AT A GLANCE

 

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SUMMARY

FIG 9 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION

FIG 10 SNAPSHOT OF GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE (2016)

FIG 11 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 12 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 13 GLOBAL ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 14 GLOBAL ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)

FIG 15 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)

FIG 16 WORLDWIDE MAJOR MARKETS FOR TRANSDERMAL DRUG DELIVERY SYSTEMS

FIG 17 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SNAPSHOT

FIG 18 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 19 NORTH AMERICA PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 20 NORTH AMERICA ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 21 NORTH AMERICA ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)

FIG 22 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)

FIG 23 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)

FIG 24 EUROPE TRANSDERMAL DRUG DELIVERY SYSTMES MARKET SNAPSHOT

FIG 25 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 26 EUROPE PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 27 EUROPE ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 28 EUROPE ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)

FIG 29 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)

FIG 30 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)

FIG 31 APAC TRANSDERMAL DRUG DELIVERY SYSTMES MARKET SNAPSHOT

FIG 32 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 33 APAC PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 34 APAC ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 35 APAC ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)

FIG 36 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)

FIG 37 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)

FIG 38 LAMEA TRANSDERMAL DRUG DELIVERY SYSTMES MARKET SNAPSHOT

FIG 39 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 40 LAMEA PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 41 LAMEA ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)

FIG 42 LAMEA ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)

FIG 43 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)

FIG 44 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)

FIG 45 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SHARE OF KEY PLAYERS (2016)

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry